Pure Global
DRKS00003771

Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma

Societe Internationale d'Oncologie Pediatrique·Not Applicable·Deutsches Register Klinischer StudienRecruiting
Study focus
Disease/Condition
Brain and Central Nervous System Tumors
Study type
Interventional
Sponsor & location
Primary sponsor
Societe Internationale d'Oncologie Pediatrique
Funder
Bitte wenden Sie sich an den Sponsor / Please refer to primary sponsor
Location
Austria,Belgium,Croatia,Denmark,France,Germany,Italy,Norway,Poland,Portugal,Switzerland,United Kingd
Timeline & enrollment
Phase
Not Applicable
Start date
N/A
End date
N/A
Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This clinical trial is studying giving radiation therapy or combination chemotherapy to see how well it works in treating patients with clinically or radiologically progressive low-grade gliomas.

ICD-10 classifications
Malignant neoplasm: Overlapping lesion of brain and other parts of central nervous systemMalignant neoplasm: Central nervous system, unspecifiedBenign neoplasm of brain and other parts of central nervous systemMalignant neoplasm of brainSecondary malignant neoplasm of other and unspecified parts of nervous system
Data source
Registry
Deutsches Register Klinischer Studien
Trial ID
DRKS00003771
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for DRKS00003771 through Pure Global AI's free database. This Not Applicable trial is sponsored by Societe Internationale d'Oncologie Pediatrique and is currently Recruiting. The study focuses on Brain and Central Nervous System Tumors.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Deutsches Register Klinischer Studien data, helping medical device and pharmaceutical companies navigate clinical research efficiently.